title: Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
abstract: BACKGROUND
  We are investigating a double transgenic rat (dTGR) model, in which rats transgenic for the human angiotensinogen and renin genes are crossed. These rats develop moderately severe hypertension but die of end-organ cardiac and renal damage by week 7. The heart shows necrosis and fibrosis, whereas the kidneys resemble the hemolytic-uremic syndrome vasculopathy. Surface adhesion molecules (ICAM-1 and VCAM-1) are expressed early on the endothelium, while the corresponding ligands are found on circulating leukocytes. Leukocyte infiltration in the vascular wall accompanies PAI-1, MCP-1, iNOS and Tissue Factor expression. Furthermore we show evidence that Ang II causes the upregulation of NF-kB in our model.
  
  
  METHODS
  We started PDTC-treatment on four weeks old dTGR (200 mg/kg sc) and age-matched SD rats. Blood-pressure- and albuminuria- measurements were monitored during the treatment period (four weeks). The seven weeks old animals were killed, hearts and kidneys were isolated and used for immunohistochemical-and electromobility shift assay analysis.
  
  
  RESULTS
  Chronic treatment with the antioxidant PDTC decreased blood pressure (162 plus minus 8 vs. 190 plus minus 7 mm Hg, p = 0.02). Cardiac hypertrophy index was significantly reduced (4.90 plus minus 0.1 vs. 5.77 plus minus 0.1 mg/g, p < 0.001) compared to dTGR. PDTC reduced 24 h albuminuria by 85 % (2.7 plus minus 0.5 vs. 18.0 plus minus 3.4 mg/d, p < 0.001) and prevented death significantly. Vascular injury was ameliorated in small renal and cardiac vessels. PDTC inhibited NF-kappaB binding activity in heart and kidney. Immunohistochemical analysis shows increased expression of the p65 NF-kappaB subunit in the endothelium, smooth muscles cells of damaged small vessels, infiltrated cells, glomeruli, tubuli and collecting ducts of dTGR. PDTC markedly reduced the immunoreactivity of p65.
  
  
  CONCLUSIONS
  Our data show that inhibition of NF-kappaB by PDTC markedly reduces inflammation, iNOS expression in the dTGR most likely leading to decreased cytotoxicity, and cell proliferation. Thus, NF-kappaB activation plays an important role in ANG II-induced end-organ damage.
authors.affiliation: Franz Volhard Clinic, Charite' and Max Delbrück Center for Molecular Medicine, Berlin, Humboldt University of Berlin, Germany. theuer@fvk-berlin.de
authors.forename: Juergen
authors.initials: J
authors.lastname: Theuer
authors.forename: Ralf
authors.initials: R
authors.lastname: Dechend
authors.forename: Dominik N
authors.initials: DN
authors.lastname: Muller
authors.forename: Joon-Keun
authors.initials: JK
authors.lastname: Park
authors.forename: Anette
authors.initials: A
authors.lastname: Fiebeler
authors.forename: Peter
authors.initials: P
authors.lastname: Barta
authors.forename: Detlev
authors.initials: D
authors.lastname: Ganten
authors.forename: Hermann
authors.initials: H
authors.lastname: Haller
authors.forename: Rainer
authors.initials: R
authors.lastname: Dietz
authors.forename: Friedrich C
authors.initials: FC
authors.lastname: Luft
mesh_terms: D000804:Angiotensin II / Q000009:adverse effects*; D000808:Angiotensinogen / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified; D006332:Cardiomegaly / Q000139:chemically induced / Q000517:prevention & control; D024202:Electrophoretic Mobility Shift Assay; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D023421:Models, Animal; D009205:Myocarditis / Q000139:chemically induced / Q000517:prevention & control*; D016328:NF-kappa B / Q000378:metabolism*; D009336:Necrosis; D009393:Nephritis / Q000139:chemically induced / Q000517:prevention & control*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D018384:Oxidative Stress; D011392:Proline / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012083:Renin / Q000235:genetics / Q000378:metabolism; D013859:Thiocarbamates / Q000494:pharmacology; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D016328:NF-kappa B; D013859:Thiocarbamates; D019010:Vascular Cell Adhesion Molecule-1; D000808:Angiotensinogen; D000804:Angiotensin II; D018799:Intercellular Adhesion Molecule-1; C066229:prolinedithiocarbamate; D011392:Proline; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D012083:Renin